EQUUS TOTAL RETURN, INC. (EQS) AI Dilution Summary

The company's stated funding position rests on cash of $219,000 at the last reported balance-sheet date, 2026-06-30, against 14,506,696 shares outstanding. Every instrument disclosed carries a fixed contractual price, so dilution here is driven primarily by the February 2025 common stock purchase warrants, 1,999,999 shares underlying in total at a $1.50 exercise price; the share count is set at issuance and does not move with the market price.